ME Therapeutics Holdings, Inc. (TSE:METX) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
ME Therapeutics Holdings Inc., a Vancouver-based biotech firm specializing in innovative cancer immunotherapies, has announced CEO Dr. Salim Dhanji’s participation in the Bloom Burton & Co. Healthcare Investor Conference and an interview on CSE TV. The conference, which provides a platform for one-on-one investor meetings, will be held in Toronto on April 16-17, 2024. These events mark a strategic effort by ME Therapeutics to increase investor awareness as they continue to progress in the field of myeloid targeted immuno-oncology research.
For further insights into TSE:METX stock, check out TipRanks’ Stock Analysis page.